Taotao Zhou Selected Research

Taotao Zhou Research Topics

Disease

11	Neoplasms (Cancer) 11/2023 - 01/2015
6	Sclerosing Cholangitis 11/2023 - 01/2020
5	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2015
5	Cholangiocarcinoma 01/2023 - 03/2018
4	Liver Diseases (Liver Disease) 11/2023 - 01/2020
3	Necrosis 11/2023 - 01/2023
3	Autoimmune Hepatitis 01/2023 - 12/2021
3	Cholangitis 01/2022 - 03/2018
3	Pathologic Constriction (Stenosis) 01/2020 - 03/2018
2	Inflammation (Inflammations) 03/2024 - 11/2023
2	Carcinoma (Carcinomatosis) 08/2023 - 05/2023
2	COVID-19 01/2022 - 11/2020
1	Hepatitis C 04/2024
1	Congenital Abnormalities (Deformity) 11/2023
1	Hypoxia (Hypoxemia) 11/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2023
1	Stomach Neoplasms (Stomach Cancer) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023
1	Alveolar echinococcosis 01/2023
1	Anemia 01/2022
1	Thyroiditis 01/2022
1	Hypertension (High Blood Pressure) 09/2021
1	Hyperthyroidism 09/2021
1	Mucositis 09/2021
1	Diarrhea 09/2021
1	End Stage Liver Disease 02/2021
1	Disease Progression 11/2020
1	Cytokine Release Syndrome 11/2020
1	Infections 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Liver Failure 03/2018

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2020
3	PlatinumIBA 08/2023 - 01/2021
2	CytokinesIBA 04/2024 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 09/2021
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 07/2021
2	AntigensIBA 11/2023 - 07/2021
2	Gemcitabine FDA Link 01/2022 - 01/2021
2	PolymersIBA 01/2020 - 01/2020
1	PAR-1 ReceptorIBA 03/2024
1	atezolizumabIBA 01/2024
1	lenvatinibIBA 01/2024
1	Bevacizumab (Avastin)FDA Link 01/2024
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2023
1	roxadustatIBA 11/2023
1	InterleukinsIBA 11/2023
1	PlasticsIBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	clonidine-displacing substance (ClDS)IBA 09/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	Fluorouracil (Carac)FDA LinkGeneric 05/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2023
1	Leucovorin (Folinic Acid)FDA Link 05/2023
1	Docetaxel (Taxotere)FDA Link 05/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2023
1	N- (1,3- benzodioxol- 5- ylmethyl)- 2,6- dichlorobenzamideIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	olaparibIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	BilirubinIBA 12/2021
1	AlbuminsIBA 12/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Alkaline PhosphataseIBA 12/2021
1	cabozantinibIBA 09/2021
1	VaccinesIBA 07/2021
1	Fetal Proteins (Fetoprotein)IBA 07/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2020
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2020
1	Cephalothin (Cefalotin)FDA Link 01/2020
1	nasIBA 06/2019
1	Liposomes (Liposome)IBA 01/2015

Therapy/Procedure

15	Therapeutics 01/2024 - 03/2018
5	Liver Transplantation 11/2023 - 01/2020
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
3	Immunotherapy 11/2023 - 07/2021
3	Radiofrequency Ablation 01/2023 - 09/2021
2	Transplantation 07/2023 - 03/2018
2	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2020
1	Palliative Care (Palliative Therapy) 02/2023
1	Drug Tapering 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Intravenous Injections 01/2015